12 Healthcare Stocks Moving In Monday's After-Market Session


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Gainers

Trxade Group (NASDAQ:MEDS) shares increased by 13.72% to $4.89 during Monday's after-market session. Trading volume for this security closed at 30.1K, accounting for 35.0% of its average full-day volume over the last 100 days. The company's market cap stands at $37.6 million.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 9.41% to $9.3. Today's trading volume for this security ended up closing at 519.3K shares, which is 3.14 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q3 earnings came out today.

Equillium (NASDAQ:EQ) shares rose 9.01% to $3.87. Equillium's trading volume hit 4.5K shares by close, accounting for 0.57% of its average volume over the last 100 days. The market value of their outstanding shares is at $68.4 million.

Fulgent Genetics (NASDAQ:FLGT) shares rose 8.67% to $33.7. Fulgent Genetics's trading volume hit 27.6K shares by close, accounting for 2.9% of its average volume over the last 100 days. The company's market cap stands at $731.2 million. As per the press release, Q3 earnings came out today.

Affimed (NASDAQ:AFMD) stock increased by 7.23% to $4.0. Trading volume for this security closed at 132.7K, accounting for 15.15% of its average full-day volume over the last 100 days. The company's market cap stands at $304.9 million.

Altimmune (NASDAQ:ALT) shares rose 6.31% to $8.33. Today's trading volume for this security ended up closing at 106.4K shares, which is 7.03 percent of its average volume over the last 100 days. The company's market cap stands at $167.5 million.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


 

Losers

Arena Pharmaceuticals (NASDAQ:ARNA) stock decreased by 19.93% to $70.0 during Monday's after-market session. Arena Pharmaceuticals's trading volume hit 112.6K shares by close, accounting for 18.19% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.9 billion. As per the news, the Q3 earnings report came out today.

Neurocrine Biosciences (NASDAQ:NBIX) stock fell 12.75% to $89.71. Neurocrine Biosciences's trading volume hit 136.2K shares by close, accounting for 16.96% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.3 billion. As per the press release, Q3 earnings came out today.

Revance Therapeutics (NASDAQ:RVNC) stock fell 9.43% to $25.0. Today's trading volume for this security ended up closing at 14.9K shares, which is 2.46 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q3 earnings came out today.

TherapeuticsMD (NASDAQ:TXMD) shares decreased by 9.22% to $1.38. At the close, TherapeuticsMD's trading volume reached 86.8K shares. This is 3.14% of its average volume over the last 100 days. The company's market cap stands at $374.9 million. As per the news, the Q3 earnings report came out today.

La Jolla Pharmaceutical (NASDAQ:LJPC) stock fell 7.41% to $4.0. La Jolla Pharmaceutical's trading volume hit 7.2K shares by close, accounting for 1.82% of its average volume over the last 100 days. The market value of their outstanding shares is at $109.1 million.

Zogenix (NASDAQ:ZGNX) shares declined by 6.93% to $21.5. This security traded at a volume of 254.3K shares come close, making up 21.29% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out today.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Health CareAfter-Hours CenterMoversGeneral